Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study
about
Therapeutic Strategies in HCC: Radiation ModalitiesCurrent and future treatments for hepatocellular carcinomaTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsRadioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveRadioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesImage-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspectiveTheranostic Imaging of Yttrium-90Yttrium-90 microspheres: a review of its emerging clinical indicationsEvaluation of 99mTc labelled poly lactic acid microspheres for diagnostic radioembolization.VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB TrialsTechnology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma.A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma.Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers.Radioembolization of yttrium-90 microspheres for hepatic malignancy.Transarterial therapies for hepatocellular carcinoma.Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.Trans-arterial hepatic radioembolisation of yttrium-90 microspheres.Radionuclide therapy of hepatocellular carcinoma.Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio.Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment EfficacyTreatment of hepatocellular carcinoma by means of radiopharmaceuticals.Major liver resection for hepatocellular carcinoma in the morbidly obese: a proposed strategy to improve outcome.A review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Treatment of large and advanced hepatocellular carcinoma.Evaluation of hepatic angiography procedures and bremsstrahlung imaging in selective internal radiation therapy: a two-year single-center experience.Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial.A first report of radioembolization for hepatic metastases from ocular melanoma.Treating hepatocellular carcinoma with 90Y-bearing microspheres: a reviewHigh impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization.State of the art: radiolabeled microspheres treatment for liver malignancies.Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer.Update on yttrium-90-based radio-embolization for treatment of hepatocellular carcinoma.The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review.How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide.(90)Y-glass microspheres for hepatic neoplasia.Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
P2860
Q26738658-3C71E376-1891-4F60-9F8A-3C6B1D079A08Q26801211-1585E8B1-C82D-4F27-A80E-A0AE3B6DB42DQ26852174-1B69D3E2-EF52-4F8B-8A00-23656E58DF85Q26998661-FEA233F9-3053-4682-BA80-118033CE3C19Q27023616-9C5A2559-DBEF-47D5-8794-4D6B32A9C1A3Q28080761-8FF9AEE1-BAAF-4ACC-AC4E-05D267AF4B01Q28083044-AE82F3FF-0E0E-41B2-9270-C735D859B8C8Q28083856-72E566C3-F62A-4739-ABCE-27F65D68D5F9Q30886124-C8FBC330-7BD2-44F8-A749-F809031E027FQ31162270-C5E28BD4-392B-42DE-8E7C-F4742A4E9236Q33245966-DDD1569C-4FEC-4F24-808D-702135E28507Q33593257-C2483207-13A8-46DB-B0B1-35A406E0B47DQ33607208-F9406B35-CF02-4C36-BBB7-9CDC61A340F0Q34062165-139845B4-740D-41F9-A67A-790C08BE94C8Q34563515-16F9A551-D729-424E-BB04-EC81E59C9C34Q34628257-693EF8C5-0AED-4476-A809-6947292CBEABQ34695917-705E75A2-2C8B-4C4C-B279-465A77DE0E4FQ34874473-20DC5F01-E3C4-4EBC-ADD2-275497080B72Q34991390-F21424A5-C92A-4C00-BAF3-47B951E2AFB7Q34991395-C0345226-3B1F-49ED-B2C0-4976261AD1EFQ35738820-8D4A89BD-9DCC-4E4B-8247-79B309035248Q36184640-2D91E650-A3B5-490B-9649-05D9FBE22A72Q36194191-801DF213-60A8-45EE-A764-10DA6CCE3853Q36201164-BE6665A2-6A3B-40F1-85E9-7507A876ABD7Q36889746-476E17D0-6FFD-458B-B0F6-806BA4B7A7F0Q36899620-7CCF2DB8-282D-4E0F-B830-140478E89BAFQ37072529-C1ADDD52-864B-4624-A919-459CF298D41BQ37084257-77A6AEAB-CF64-4DC9-B848-BB71028565B9Q37367343-7E0E026D-933D-4834-981B-B77CFFF092E0Q37393973-1FC65C7C-A0A3-47AF-9D67-B8872BFE6801Q37474833-BC3415E8-F737-4C16-B8C7-D0849FE1AE08Q37565602-2EC008F8-589C-4995-9277-E69F41C91E02Q37693928-0A33BEE0-1A12-41B3-9397-4173F4099BD1Q37769585-C4C6C662-67EA-4D27-86C8-B1F316AF3326Q38022739-B2B34560-7A1B-4ACB-B4AE-40B47FF6DE73Q38182093-00D264EE-4106-491F-B3FA-981CAB8F2FD4Q38398444-6096867C-7A2A-4170-AA02-6D5965FB3277Q38465831-1B93DEEF-62D9-4155-B21A-84F6484DBD9FQ38538075-8088F187-A2DB-4EB3-BD6E-1F59ABAD60DEQ38652404-9CC92B06-63D9-4F93-A381-FADF7481577C
P2860
Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Treatment of inoperable hepato ...... pheres: a phase I and II study
@ast
Treatment of inoperable hepato ...... pheres: a phase I and II study
@en
type
label
Treatment of inoperable hepato ...... pheres: a phase I and II study
@ast
Treatment of inoperable hepato ...... pheres: a phase I and II study
@en
prefLabel
Treatment of inoperable hepato ...... pheres: a phase I and II study
@ast
Treatment of inoperable hepato ...... pheres: a phase I and II study
@en
P2093
P2860
P356
P1476
Treatment of inoperable hepato ...... pheres: a phase I and II study
@en
P2093
Metreweli C
P2860
P2888
P304
P356
10.1038/BJC.1994.436
P407
P577
1994-11-01T00:00:00Z
P5875
P6179
1042684896